Personalized Dosimetry in the Context of Radioiodine Therapy for Differentiated Thyroid Cancer

Personalized Dosimetry in the Context of Radioiodine Therapy for Differentiated Thyroid Cancer

The most frequent thyroid cancer is Differentiated Thyroid Cancer (DTC) representing more than 95% of cases. A suitable choice for the treatment of DTC is the systemic administration of 131-sodium or potassium iodide. It is an effective tool used for the irradiation of thyroid remnants, microscopic...

Full description

Bibliographic Details
Main Authors: Massimiliano Pacilio, Miriam Conte, Viviana Frantellizzi, Maria Silvia De Feo, Antonio Rosario Pisani, Andrea Marongiu, Susanna Nuvoli, Giuseppe Rubini, Angela Spanu, Giuseppe De Vincentis
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Diagnostics
Subjects:
Differentiated Thyroid Cancer
personalized dosimetry
radioiodine therapy
absorbed dose
Online Access:https://www.mdpi.com/2075-4418/12/7/1763

Internet

https://www.mdpi.com/2075-4418/12/7/1763

Similar Items